Acorah Software Products - Accounts Production 14.5.601 false true 6 December 2023 7 December 2022 false 7 December 2023 31 December 2023 31 December 2023 14526381 Mr Haider Alhaydari iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14526381 2023-12-06 14526381 2023-12-31 14526381 2023-12-07 2023-12-31 14526381 frs-core:CurrentFinancialInstruments 2023-12-31 14526381 frs-core:Non-currentFinancialInstruments 2023-12-31 14526381 frs-core:FurnitureFittings 2023-12-31 14526381 frs-core:FurnitureFittings 2023-12-07 2023-12-31 14526381 frs-core:FurnitureFittings 2023-12-06 14526381 frs-core:NetGoodwill 2023-12-31 14526381 frs-core:NetGoodwill 2023-12-07 2023-12-31 14526381 frs-core:NetGoodwill 2023-12-06 14526381 frs-core:ShareCapital 2023-12-31 14526381 frs-core:RetainedEarningsAccumulatedLosses 2023-12-07 2023-12-31 14526381 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 14526381 frs-bus:PrivateLimitedCompanyLtd 2023-12-07 2023-12-31 14526381 frs-bus:FilletedAccounts 2023-12-07 2023-12-31 14526381 frs-bus:SmallEntities 2023-12-07 2023-12-31 14526381 frs-bus:AuditExemptWithAccountantsReport 2023-12-07 2023-12-31 14526381 frs-bus:SmallCompaniesRegimeForAccounts 2023-12-07 2023-12-31 14526381 frs-bus:Director1 2023-12-07 2023-12-31 14526381 frs-countries:EnglandWales 2023-12-07 2023-12-31 14526381 2022-12-06 14526381 2023-12-06 14526381 2022-12-07 2023-12-06 14526381 frs-core:CurrentFinancialInstruments 2023-12-06 14526381 frs-core:Non-currentFinancialInstruments 2023-12-06 14526381 frs-core:ShareCapital 2022-12-06 14526381 frs-core:ShareCapital 2023-12-06 14526381 frs-core:RetainedEarningsAccumulatedLosses 2022-12-07 2023-12-06 14526381 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2022-12-06 14526381 frs-core:RetainedEarningsAccumulatedLosses 2023-12-06
Registered number: 14526381
ALPHA PHARMACEUTICS LIMITED
Unaudited Financial Statements
For the Period 7 December 2023 to 31 December 2023
ZA LTD
FMAAT AND FFA
Contents
Page
Accountants' Report 1
Balance Sheet 2—3
Statement of Changes in Equity 4
Notes to the Financial Statements 5—7
Page 1
Accountants' Report
Report of the Accountant to the director of ALPHA PHARMACEUTICS LIMITED
These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the period ended 31 December 2023.
We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.
On the Balance Sheet you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give “a true and fair view”.
You have determined that the company is exempt from the statutory requirement for an audit for this accounting period. Therefore, the financial statements are unaudited.
The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.
Signed
ZA Limited
08/04/2024
ZA LTD
FMAAT AND FFA
Page 1
Page 2
Balance Sheet
Registered number: 14526381
31 December 2023 6 December 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 487,523 487,523
Tangible Assets 5 142,543 142,543
630,066 630,066
CURRENT ASSETS
Stocks 6 98,773 105,447
Debtors 7 91,508 68,548
Cash at bank and in hand 71,261 30,634
261,542 204,629
Creditors: Amounts Falling Due Within One Year 8 (572,593 ) (519,845 )
NET CURRENT ASSETS (LIABILITIES) (311,051 ) (315,216 )
TOTAL ASSETS LESS CURRENT LIABILITIES 319,015 314,850
Creditors: Amounts Falling Due After More Than One Year 9 (469,204 ) (466,193 )
NET LIABILITIES (150,189 ) (151,343 )
CAPITAL AND RESERVES
Called up share capital 10 1 1
Profit and Loss Account (150,190 ) (151,344 )
SHAREHOLDERS' FUNDS (150,189) (151,343)
Page 2
Page 3
For the period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Haider Alhaydari
Director
08/04/2024
The notes on pages 5 to 7 form part of these financial statements.
Page 3
Page 4
Statement of Changes in Equity
Share Capital Profit and Loss Account Total
£ £ £
As at 7 December 2022 1 - 1
Loss for the year and total comprehensive income - (151,344 ) (151,344)
As at 6 December 2023 and 7 December 2023 1 (151,344 ) (151,343)
Profit for the period and total comprehensive income - 1,154 1,154
As at 31 December 2023 1 (150,190 ) (150,189)
Page 4
Page 5
Notes to the Financial Statements
1. General Information
ALPHA PHARMACEUTICS LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 14526381 . The registered office is 20 Porchester Road, 20 Porchester Road, KT1 3PS.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods.
2.3. Intangible Fixed Assets and Amortisation - Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the separable net assets. It is amortised to profit and loss account over its estimated economic life of 0 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 25% on reducing balance method
2.5. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 4 (2023: 4)
4 4
4. Intangible Assets
Goodwill
£
Cost
As at 7 December 2023 487,523
As at 31 December 2023 487,523
Net Book Value
As at 31 December 2023 487,523
As at 7 December 2023 487,523
Page 5
Page 6
5. Tangible Assets
Fixtures & Fittings
£
Cost
As at 7 December 2023 190,057
As at 31 December 2023 190,057
Depreciation
As at 7 December 2023 47,514
As at 31 December 2023 47,514
Net Book Value
As at 31 December 2023 142,543
As at 7 December 2023 142,543
6. Stocks
31 December 2023 6 December 2023
£ £
Finished goods 98,773 105,447
7. Debtors
31 December 2023 6 December 2023
£ £
Due within one year
Other debtors 91,508 68,548
8. Creditors: Amounts Falling Due Within One Year
31 December 2023 6 December 2023
£ £
Trade creditors 211,366 242,414
Other creditors 361,227 277,431
572,593 519,845
9. Creditors: Amounts Falling Due After More Than One Year
31 December 2023 6 December 2023
£ £
Bank loans 469,204 466,193
Page 6
Page 7
10. Share Capital
31 December 2023 6 December 2023
£ £
Allotted, Called up and fully paid 1 1
Page 7